Armistice Capital holds 8.9M shares in Travere Therapeutics as rare kidney disease stock climbs 110% following FILSPARI's ...

LTR Pharma has completed a key extractables study for its SPONTAN intranasal spray for erectile dysfunction and kicked off a ...

The company received USFDA approval for Doxorubicin Hydrochloride Injection, which will be use for the treatment of Ovarian ...

Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...

The Board of Investment says that the local pharmaceutical expenditure records a value of USD 750 million, with a projected five-year compound annual growth rate (CAGR) of 4.1%. At present, 85% of ...

Move over, cats with nine lives. A new longevity drug for dogs aims to extend the life of Fido while also helping humans live ...

Mesoblast Limited (NASDAQ:MESO) is one of the 7 Best ASX Stocks to Buy Now. The company announced that it received 7 years of ...

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

An investigation has uncovered evidence of significant misreporting, raising new concerns about the approval and long-term use of ticagrelor over the past decade. In a follow-up investigation into the ...